HomeEGTX • STO
add
Egetis Therapeutics AB (publ)
Previous close
kr 5.00
Day range
kr 4.94 - kr 5.03
Year range
kr 3.03 - kr 7.67
Market cap
1.79B SEK
Avg Volume
532.18K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 14.50M | 4.32% |
Operating expense | 80.00M | -7.08% |
Net income | -77.60M | -7.93% |
Net profit margin | -535.17 | -3.46% |
Earnings per share | — | — |
EBITDA | -77.82M | -3.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 202.60M | 5.19% |
Total assets | 654.40M | 1.21% |
Total liabilities | 299.30M | 22.11% |
Total equity | 355.10M | — |
Shares outstanding | 359.24M | — |
Price to book | 5.05 | — |
Return on assets | -28.47% | — |
Return on capital | -39.58% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -77.60M | -7.93% |
Cash from operations | -59.00M | -4.61% |
Cash from investing | -2.40M | — |
Cash from financing | -7.80M | -1,200.00% |
Net change in cash | -70.20M | -18.58% |
Free cash flow | -37.40M | -40.87% |
About
Founded
2006
Website
Employees
40
